Call me naïve – but I still find this revolting.

According to many reports (this one from the Newark Star-Ledger), “A controversy over the cholesterol-fighting medicine Vytorin has spawned at least 33 lawsuits by consumers who are angry over the way Merck and Schering-Plough promoted the medicine to lower low-density lipoprotein.”

"By failing to timely release the results of the Enhance trial, which demonstrates that Zetia does not reduce or slow the build-up of arterial plaque, defendants reaped billions of dollars in profits that they otherwise would not have obtained," the lawsuits allege.

In addition, the plaintiffs claim they might not have purchased the pricey drugs if they had known they didn't work any better than the generic form of Zocor, which is much less expensive.

Here’s a link to the complete article:

http://www.nj.com/business/ledger/index.ssf?/base/business-1/1212122169217600.xml&coll=1

In a statement, Merck said it would "vigorously defend" itself against the allegations.

And “amen” to that.